You are here

AusPAR: Indacaterol (as acetate) / glycopyrronium (as bromide) / mometasone furoate

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

22 April 2021
AusPAR Details
AusPAR
Active Ingredient
Indacaterol (as acetate) / glycopyrronium (as bromide) / mometasone furoate
Product Name
Enerzair Breezhaler
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Submission Number
PM-2019-02514-1-5
Submission Type
New combination of active ingredients
Decision
Approved
AusPAR Date
6 April 2021
Publication Date

22 April 2021